Gengraf and Multivitamin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gengraf (cyclosporine) and Multivitamin (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e). Common drug interactions include skin hypertrophy among females and blood pressure increased among males.

The phase IV clinical study analyzes what interactions people have when they take Gengraf and Multivitamin. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Gengraf?

Gengraf has active ingredients of cyclosporine. eHealthMe is studying from 960 Gengraf users. Check the latest studies of Gengraf.

What is Multivitamin?

Multivitamin has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 83,597 Multivitamin users. Check the latest studies of Multivitamin.



On Jul, 20, 2026

18 people who take Gengraf and Multivitamin together, and have interactions are studied.

Gengraf and Multivitamin drug interactions.

What are the common drug interactions of Gengraf and Multivitamin, by gender? *:

female:

  1. Skin hypertrophy (skin cells enlarges)
  2. Skin induration (an abnormally hard spot or area on the skin)
  3. Skin tightness
  4. Soft tissue disorder (disease of soft tissue)
  5. Spinal compression fracture (fracture due to spinal compression on bone)
  6. Stress
  7. Syncope (loss of consciousness with an inability to maintain postural tone)
  8. Tooth loss
  9. Upper extremity mass
  10. Upper limb fracture

male:

  1. Blood pressure increased
  2. Diarrhoea
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Abdominal pain
  5. Arthralgia (joint pain)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Blood creatine increased
  8. Blood glucose increased
  9. Cytomegalovirus viraemia (cytomegalo virus in blood stream)
  10. Depression

What are the common drug interactions of Gengraf and Multivitamin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Apathy
  2. Arthralgia (joint pain)
  3. Asthenia (weakness)
  4. Decreased appetite
  5. Fatigue (feeling of tiredness)
  6. Haematocrit decreased
  7. Hyperaesthesia
  8. Myalgia (muscle pain)
  9. Oedema peripheral (superficial swelling)
  10. Pain of skin

60+:

  1. Blood pressure increased
  2. Fall
  3. Bacteraemia (presence of bacteria in the blood)
  4. Blood glucose increased
  5. Cervical vertebral fracture
  6. Confusional state
  7. Death
  8. Depression
  9. Diarrhoea
  10. Disease complication

What are the existing conditions these people have? *

  1. High Blood Pressure: 5 people, 27.78%
  2. Hyperkalemia (damage to or disease of the kidney): 3 people, 16.67%
  3. High Blood Cholesterol: 3 people, 16.67%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 11.11%
  6. Cardiac Disorder: 2 people, 11.11%
  7. Stress And Anxiety: 2 people, 11.11%
  8. Insomnia (sleeplessness): 2 people, 11.11%
  9. Diabetes: 2 people, 11.11%
  10. Chronic Kidney Disease: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Gengraf and Multivitamin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gengraf and Multivitamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gengraf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Multivitamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gengraf and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Multivitamin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine and ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e (the active ingredients of Gengraf and Multivitamin, respectively), and Gengraf and Multivitamin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: